Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection (injection) from Fresenius Kabi USA, LLC with status Current. The shortage was first posted on 02/20/2018.
Shortage Details
- Status
- Current
- Company
- Fresenius Kabi USA, LLC
- Package NDC
- 63323-461-57
- Dosage Form
- Injection
- Presentation
- Sensorcaine, Injection, 2.5 mg/1 mL; .005 mg/1 mL (NDC 63323-461-57)
- Initial Posting
- 02/20/2018
- Revised Date